PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company’s Proprietary Neuromodulation Technology in ALS
"We are gratified to see these latest patent issuances," said Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO. "We have been pioneering the application of neuromodulation to ALS, and these ...